1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. GREENWICH LIFESCIENCES INC
Greenwich LifeSciences Inc XNAS: GLSI

Greenwich LifeSciences Inc Live Stock Price Today, Share Analysis and Chart

about

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane pepti...

Read More
11.42 0.03 (0.26%)
26.32% Fall from 52W High
89,988
XNAS Volume

XNAS 11 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
0.3 / 100
Momentum Score
Technically Neutral
44.6 / 100
Analyst Price Target
No estimates available

5

S

7

W

1

O

2

T

SWOT Analysis

Greenwich LifeSciences Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..